+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Electronic Drug Delivery System Market Research Report by Type, Indication, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4896642
  • Report
  • April 2022
  • Region: Global
  • 194 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Amgen, Inc.
  • Bayer AG
  • Companion Medical
  • F.Hoffmann-La Roche, Ltd.
  • Insulet Corporation
  • Merck Group
The Global Electronic Drug Delivery System Market size was estimated at USD 9,322.01 million in 2021, USD 10,276.03 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.81% to reach USD 17,266.04 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Electronic Drug Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps.
  • Based on Indication, the market was studied across Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple Sclerosis.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Electronic Drug Delivery System market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Electronic Drug Delivery System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Electronic Drug Delivery System Market, including Amgen, Inc., Astrazeneca PLC, Bayer AG, Canè SPA, Companion Medical, Debiotech S.A., F.Hoffmann-La Roche, Ltd., Findair SP. Z O. O., Insulet Corporation, Medtronic PLC, Merck Group, Novo Nordisk, Tandem Diabetes Care, Inc., United Therapeutics Corporation, and Vicentra B.V..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Electronic Drug Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Electronic Drug Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Electronic Drug Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Electronic Drug Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Electronic Drug Delivery System Market?
6. What is the market share of the leading vendors in the Global Electronic Drug Delivery System Market?
7. What modes and strategic moves are considered suitable for entering the Global Electronic Drug Delivery System Market?
Frequently Asked Questions about the Global Electronic Drug Delivery System Market

What is the estimated value of the Global Electronic Drug Delivery System Market?

The Global Electronic Drug Delivery System Market was estimated to be valued at $9322.0 Million in 2021.

What is the growth rate of the Global Electronic Drug Delivery System Market?

The growth rate of the Global Electronic Drug Delivery System Market is 10.8%, with an estimated value of $17266.0 Million by 2027.

What is the forecasted size of the Global Electronic Drug Delivery System Market?

The Global Electronic Drug Delivery System Market is estimated to be worth $17266.0 Million by 2027.

Who are the key companies in the Global Electronic Drug Delivery System Market?

Key companies in the Global Electronic Drug Delivery System Market include Amgen, Inc., Astrazeneca PLC, Bayer AG, Canè SPA, Companion Medical, Debiotech S.A., F.Hoffmann, La Roche, Ltd. and Insulet Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen, Inc.
  • Bayer AG
  • Companion Medical
  • F.Hoffmann-La Roche, Ltd.
  • Insulet Corporation
  • Merck Group

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of target diseases
5.1.1.2. Favorable reimbursement scenario in major markets
5.1.1.3. Advancements in technologies and designs
5.1.2. Restraints
5.1.2.1. Preference for alternative drug delivery methods and the probability of errors
5.1.3. Opportunities
5.1.3.1. Increasing demand for biologics and Mabs
5.1.3.2. Growth opportunities in emerging markets
5.1.4. Challenges
5.1.4.1. Unfavorable reimbursement structure in developing countries
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Electronic Drug Delivery System Market, by Type
6.1. Introduction
6.2. Electronic Autoinjectors
6.3. Electronic Inhalers
6.4. Electronic Injection Pens
6.5. Electronic Wearable Infusion Pumps
7. Electronic Drug Delivery System Market, by Indication
7.1. Introduction
7.2. Asthma & COPD
7.3. Cardiovascular Disease
7.4. Diabetes
7.5. Multiple Sclerosis
8. Electronic Drug Delivery System Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Electronic Drug Delivery System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Electronic Drug Delivery System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Electronic Drug Delivery System Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Amgen, Inc.
13.2. Astrazeneca PLC
13.3. Bayer AG
13.4. Canè SPA
13.5. Companion Medical
13.6. Debiotech S.A.
13.7. F.Hoffmann-La Roche, Ltd.
13.8. Findair SP. Z O. O.
13.9. Insulet Corporation
13.10. Medtronic PLC
13.11. Merck Group
13.12. Novo Nordisk
13.13. Tandem Diabetes Care, Inc.
13.14. United Therapeutics Corporation
13.15. Vicentra B.V.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: DYNAMICS
FIGURE 2. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2027
FIGURE 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2027
FIGURE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 25. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 27. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY REGION, 2019-2027 (USD MILLION)
TABLE 20. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: SCORES
TABLE 92. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: BUSINESS STRATEGY
TABLE 93. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 94. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: RANKING
TABLE 95. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 96. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: MERGER & ACQUISITION
TABLE 97. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 98. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 99. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 100. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 101. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Amgen, Inc.
  • Astrazeneca PLC
  • Bayer AG
  • Canè SPA
  • Companion Medical
  • Debiotech S.A.
  • F.Hoffmann-La Roche, Ltd.
  • Findair SP. Z O. O.
  • Insulet Corporation
  • Medtronic PLC
  • Merck Group
  • Novo Nordisk
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Vicentra B.V.
Note: Product cover images may vary from those shown

Loading
LOADING...